Empagliflozin and liraglutide ameliorate HFpEF in mice via augmenting the Erbb4 signaling pathway
Xiayun Ni(University of Science and Technology of China), Jianping Weng(University of Science and Technology of China)
Cited by 16
Related Papers
Prevalence of Diabetes among Men and Women in China
|New England Journal of Medicine|2010|3.1k
Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
|Pharmacological Reviews|2021|1.1k
Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations
|Diabetes Care|2016|969
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
|The Lancet Diabetes & Endocrinology|2017|325
Standards of care for type 2 diabetes in China
|Diabetes/Metabolism Research and Reviews|2016|321